Glenna Mileson serves as Executive at Athira Pharma, Inc., where they oversee executive responsibilities. Since joining the company, Glenna Mileson has executed 10 insider transactions totaling $149.5K, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 28, 2022 involved purchasing 50,000 shares valued at $142.5K.
Glenna Mileson currently holds 159,930 shares of Athira Pharma, Inc. (ATHA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Glenna Mileson has been a net buyer of ATHA stock. They have purchased $142.5K and sold $7.0K worth of shares.
Glenna Mileson's most recent insider trade was on Dec 28, 2022, when they purchased 50,000 shares at $2.85 per share.
Get notified when new Form 4 filings are submitted
| $2.74 |
| Discretionary |
| Jun 23, 2022 | ATHA | $7.0K | Sale | 2,614 | $2.69 | Discretionary |
| Jun 22, 2022 | ATHA | $0 | Award | 10,000 | $N/A | Discretionary |
| May 18, 2022 | ATHA | $12.2K | Award | 1,721 | $7.06 | Discretionary |
| Apr 11, 2022 | ATHA | $31.9K | Option Exercise | 3,000 | $10.64 | Discretionary |
| Jan 4, 2022 | ATHA | $8.5K | Option Exercise | 6,305 | $1.35 | Discretionary |
| Nov 18, 2021 | ATHA | $11.6K | Award | 931 | $12.51 | Discretionary |
| Jun 10, 2021 | ATHA | $8.5K | Option Exercise | 6,305 | $1.35 | Discretionary |
| May 18, 2021 | ATHA | $22.5K | Award | 1,554 | $14.45 | Discretionary |